Psagot Value Holdings Ltd. Neurocrine Biosciences Inc Transaction History

Psagot Value Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$106.07 - $132.76 $1,166 - $1,460	-11 Reduced 50.0%	11 $1,000
Q3 2023 Oct 30, 2023	SELL	$94.02 - $117.1 $752 - $936	-8 Reduced 26.67%	22 $3,000
Q2 2023 Aug 03, 2023	BUY	$89.53 - $104.87 $358 - $419	4 Added 15.38%	30 $3,000
Q1 2023 Jun 20, 2023	BUY	$94.11 - $123.02 $2,446 - $3,198	26 New	26 $3,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

Stay updated on Psagot Value Holdings Ltd. with notifications on news.